Skip to main content
Log in

Effects of Interactions Between Drugs on the Renal Excretion of Trientine in RatsAcetazolamide and Furosemide Increase Trientine Excretion

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. To elucidate the effects of drug interactions on the urinary excretion of trientine in rats.

Methods. Trientine and various other drugs were intravenously administered to rats and the urinary excretion of trientine was investigated. To clarify the mechanisms of drug-drug interactions, we also investigated the effects of various drugs on spermine uptake by rat renal brush-border membrane vesicles.

Results. Cimetidine, a substrate of the H+/organic cation antiporter, and aminoglycoside antibiotics did not affect trientine excretion, while acetazolamide and furosemide, which increase the concentration of sodium ions in renal proximal tubules, increased the excretion of trientine. However, trichlormethiazide, which acts in renal distal tubules, did not affect trientine excretion. Acetazolamide and furosemide did not directly affect the Na+/spermine transporter because these diuretics had no effect on the uptake of spermine into the rat renal brush-border membrane vesicles.

Conclusions. There is no interaction between trientine and the substrate of the H+/organic cation antiporter or aminoglycoside antibiotics. However, drugs that change the concentration of sodium ions in renal proximal tubules, such as diuretics, can increase the trientine excretion since the increase in the luminal concentration of sodium ion accelerates the Na+/spermine antiporter.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. I. H. Scheinberg and I. Sternlieb. Wilson's Disease, Saunders, Philadelphia, 1984.

    Google Scholar 

  2. C. D. Marsden. Wilson's disease. Quart. J. Med. 248:959-966 (1987).

    Google Scholar 

  3. J. M. Walshe. Treatment of Wilson's disease with trientine (triethylenetetramine) dihydrochloride. Lancet. I:643-647 (1982).

    Google Scholar 

  4. M. Kobayashi, R. Tanabe, M. Sugawara, K. Iseki, and K. Miyazaki. The mechanism of excretion of trientine from the rat kidney: Trientine is not recognized by the H+/organic cation transporter. J. Pharm. Pharmacol. 49:426-429 (1997).

    Google Scholar 

  5. M. Kobayashi, H. Fujisaki, M. Sugawara, K. Iseki, and K. Miyazaki. The presence of an Na+/spermine antiporter in the rat renal brush-border membrane. J. Pharm. Pharmacol. 51:279-284 (1999).

    Google Scholar 

  6. J. Biber, B. Stieger, H. Hasse, and H. Murer. A high yield preparation for rat kidney brush-border membranes. Different behavior of lysosomal markers. Biochim. Biophys. Acta. 647:169-176 (1981).

    Google Scholar 

  7. K. Miyazaki, S. Kishino, M. Kobayashi, S. Arashima, S. Matsumoto, and T. Arita. Determination of triethylenetetramine in plasma of patients by high-performance liquid chromatography. Chem. Pharm. Bull. 38:1035-1038 (1990).

    Google Scholar 

  8. R. Tanabe, M. Kobayashi, M. Sugawara, K. Iseki, and K. Miyazaki. Uptake mechanism of trientine by rat intestinal brush-border membrane vesicles. J. Pharm. Pharmacol. 48:517-521 (1996).

    Google Scholar 

  9. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol regent. J. Biol. Chem. 193:265-275 (1951).

    Google Scholar 

  10. E. K. Jackson. Diuretics. In J. G. Hardman, A. Goodman Gilman, and L. E. Limbird (eds.), Goodman & Gilman's The Pharmacological Basis of Therapeutics (9th ed.), McGraw-Hill, New York, 1996, pp. 685-713.

    Google Scholar 

  11. M. Takano, K. Inui, T. Okano, and R. Hori. Cimetidine transport in rat renal brush-border and basolateral membrane vesicles. Life Sci. 37:1579-1585 (1985).

    Google Scholar 

  12. D. H. Russell, C. C. Levy, S. C. Schimpff, and I. A. Hawk. Urinary polyamines in cancer patients. Cancer Res. 31:1555-1558 (1971).

    Google Scholar 

  13. T. P. Waalkes, C. W. Gehrke, D. C. Tormey, R. W. Zumwalt, J. N. Hueser, K. C. Kuo, D. B. Lakings, D. L. Ahmann, and C. G. Moertel. Urinary excretion of polyamines by patients with advanced malignancy. Cancer Chemother. Reports-Part 1. 59:1103-1116 (1975).

    Google Scholar 

  14. C. Loser, U. R. Folsch, C. Paprotny, and W. Creutzfeldt. Polyamines in colorectal cancer. Evaluation of polyamine concentrations in the colon tissue, serum, and urine of 50 patients with colorectal cancer. Cancer 65:958-966 (1990).

    Google Scholar 

  15. S. Silbernagl, K. Völker, H. J. Lang, and W. H. Dantzler. Taurine reabsorption by a carrier interacting with furosemide in short and long Henle's loops of rat nephrons. Am. J. Physiol. 272:F205-F213 (1997).

    Google Scholar 

  16. F. G. Knox, F. S. Wright, S. S. Howards, and R. W. Berliner. Effect of furosemide on sodium reabsorption by proximal tubule on the dog. Am. J. Physiol. 217:192-198 (1969).

    Google Scholar 

  17. B. M. Brenner, R. I. Keimowits, F. S. Wright, and R. W. Berliner. An inhibitory effect of furosemide on sodium reabsorption by the proximal tubule of the rat nephron. J. Clin. Invest. 48:290-300 (1969).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kobayashi, M., Fujisaki, H., Sugawara, M. et al. Effects of Interactions Between Drugs on the Renal Excretion of Trientine in RatsAcetazolamide and Furosemide Increase Trientine Excretion. Pharm Res 16, 1888–1892 (1999). https://doi.org/10.1023/A:1018963712232

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018963712232

Navigation